Orthopaedic News and Research

RSS

IOF to host largest clinical bone meeting in Dubai

Healthcare professionals and key opinion leaders from throughout the Middle-East and Africa will gather in Dubai for the largest clinical bone meeting ever held in the region.

25 May 2011

Tornier announces launch of Porous Coated Affiniti Stem for shoulder joint replacement surgery

Tornier Inc. the operating subsidiary of Tornier N.V., a leading global medical device company focused on serving extremities specialists who treat orthopedic conditions of the shoulder, elbow, wrist, hand, ankle and foot, today announced the introduction of the Porous Coated Affiniti Stem for shoulder joint replacement surgery.

20 May 2011

Free NYU Physician iPad app now available in iTunes store

NYU Langone Medical Center, one of the nation's premier academic medical centers, announced today the magazine of NYU School of Medicine, NYU Physician, is now available as a free iPad app in the iTunes App Store.

19 May 2011

Zimmer launches new Trabecular Metal augments for use in knee revision surgeries

Zimmer Holdings, Inc., a global leader in musculoskeletal care, today announced the launch of a new, comprehensive range of Trabecular Metal Material augment shapes and cones for use in knee revision surgeries.

17 May 2011

Major Norwegian healthcare region signs agreement with Sectra for medical IT solutions

IT and medical technology company Sectra has been entrusted with delivering the northernmost PACS in the world. The major Norwegian healthcare region, Helse Nord, is set to use Sectra's solution and the eleven hospitals that are included in the region will share patient information and radiology images.

17 May 2011

Histogenics announces acquisition of ProChon Biotech

Histogenics Corporation, a privately held regenerative medicine company, announced today that it has acquired ProChon Biotech, Ltd. in a stock-for-stock exchange.

17 May 2011

Medical Facilities first quarter revenue increases to $51.7 million

Medical Facilities Corporation, today reported its financial results for the three-month period ended March 31, 2011.

13 May 2011

Pacira Pharmaceuticals reports net loss of $9.8 million for first quarter 2011

Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced financial results for the first quarter ended March 31, 2011, provided an update on the execution of its pre-commercial and launch strategies for EXPAREL, and reiterated 2011 financial guidance.

11 May 2011

Chicago Magazine selects three Gottlieb physicians as region's 'medical MVPs'

Three Gottlieb Memorial Hospital physicians have been selected as the region's "medical MVPs" by Chicago Magazine in their "Best Sports Medicine Doctors in Chicago and the Suburbs."

11 May 2011

IOF launches Vertebral Fracture Initiative for health professionals

Vertebral fractures are a common cause of pain and disability - and they are also powerful predictors of future spine and hip fractures. Yet there is evidence that many health professionals simply fail to recognize vertebral fractures in their patients. Even if the fractures are reported, appropriate intervention is often not initiated.

10 May 2011

PTSD occurs with significant frequency in civilian patients after traumatic event involving physical injury

Although most commonly associated with military combat, post-traumatic stress disorder (PTSD) can occur in civilians, too - and with consequences that are just as serious, according to a new review article in the Journal of the American Academy of Orthopaedic Surgeons (JAAOS). PTSD is a type of anxiety disorder that occurs after a person experiences a traumatic event involving physical injury, and occurs in 20 to 51 percent of patients with an orthopaedic injury.

9 May 2011

Surgeon turns inventor to improve recovery from rotator cuff injury

A South Wales surgeon has turned inventor with the help of a leading medical manufacturer and his surgical device is set to be used in operating theatres across the UK and the world in repairing massive tears of the shoulder’s rotator cuff previously regarded as irreparable.

5 May 2011

Symmetry Medical first quarter revenue increases 13.4% to $95.8 million

Symmetry Medical Inc., a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced first quarter 2011 financial results for the period ended April 2, 2011.

5 May 2011

NYU Langone Medical Center to establish new emergency facility

NYU Langone Medical Center broke ground today on the construction of a new emergency facility, the Center for Emergency Services, which will nearly triple the size of the current emergency department.

4 May 2011

Tips for parents to prevent child's sports injuries

With spring here and summer on the way, children are back on the field and ready to score one for the team. Unfortunately, this also means more opportunities for injury, from simple twisted ankles to serious concussions.

30 Apr 2011

Invivo Therapeutics' Chief Science Officer selected as recipient of 2011 Apple Award

InVivo Therapeutics, a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries, today announced that Chief Science Officer Dr. Christopher Pritchard, Ph.D., has been selected as the 2011 recipient of the American Spinal Injury Association's prestigious Apple Award.

30 Apr 2011

Global Health Partner revenues increase 27% to SEK 178.9 million

Global Health Partner: FIRST QUARTER 2011. Revenues increased by 27 percent to SEK 178.9 million.

28 Apr 2011

Resection arthroplasty more effective for patients with diabetic foot ulcers

A recent study published in the March issue of Foot & Ankle International, the official scientific journal of the American Orthopaedic Foot & Ankle Society describes a possible amputation alternative for patients with neuropathic ulceration of the first metatarsophalangeal or big toe joint.

28 Apr 2011

Synthes, JNJ sign merger agreement for orthopaedics business

Johnson & Johnson, the world's most comprehensive and broadly-based manufacturer of health care products, and Synthes, Inc., a premier global manufacturer of orthopaedic devices, today announced that they have entered into a definitive agreement whereby Johnson & Johnson will acquire Synthes for CHF159 per share, or $21.3 billion.

27 Apr 2011

BioInvent, ThromboGenics initiate TB-402 Phase IIb trial for VTE prophylaxis

ThromboGenics NV and co-development partner BioInvent International announce today that the first patient has been dosed in a Phase IIb trial with their novel long-acting anticoagulant TB-402 for the prophylaxis of venous thromboembolism after total hip surgery.

27 Apr 2011